ABOUT
Arch Biopartners is a biotechnology firm that focuses on the treatment of respiratory Pseudomonas aeruginosin infections. Arch Biopartners was founded in 2010. Arch Biopartners' headquarters is located in Toronto, Ontario, CA M5V 1M1.
Arch Biopartner... Arch Biopartners's Co-Founder & CEO, Richard Muruve, currently has an approval
rating of 75%. Arch Biopartners's primary competitors are
There are no competitors identified for Arch Biopartners
There have been no acquisitions found related to Arch Biopartners
Recent investment data cannot be found related to Arch Biopartners